Form 4: Avita Medical Director Suzanne Crowe Reports Acquisition of Shares and Stock Options

Director Suzanne Crowe reported the acquisition of 9,200 shares of common stock and 3,943 stock options in Avita Medical, Inc.

Summary

• On June 5, 2024, Suzanne Crowe, a director of Avita Medical, Inc. [RCEL], reported acquiring 9,200 shares of common stock.
• These shares were received as an award of Restricted Stock Units (RSUs) that vest on June 5, 2025.
• Crowe also acquired 3,943 stock options with an exercise price of $9.51, exercisable from June 5, 2025, and expiring on June 5, 2034.
• Following these transactions, Crowe beneficially owns 36,426 shares of common stock, which includes unvested RSUs and 20,560 CDIs (equating to 4,112 common shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option acquisitions by a director. While insider buying can be seen as a positive signal, this is part of a compensation package and doesn't necessarily indicate strong bullish sentiment.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The disclosure provides transparency to shareholders regarding insider transactions.
• Employees may view the director's stock ownership as a sign of confidence in the company.

Key Dates